The surgical management of tuberculosis

Area of Science:

• Pulmonary Medicine
• Infectious Diseases
• Surgical Oncology

Background:

• Rising tuberculosis incidence in the US necessitates exploring advanced treatment options.
• Multi-drug-resistant tuberculosis (MDRTB) presents significant therapeutic challenges.
• Standard medical regimens may be insufficient for certain complex TB cases.

Purpose of the Study:

• To evaluate the efficacy and safety of surgical management for patients with drug-resistant tuberculosis.
• To identify patient subgroups who may benefit from operative intervention.
• To assess the role of surgical intervention in conjunction with medical therapy.

Main Methods:

• Review of surgical cases involving patients with drug-resistant tuberculosis.
• Analysis of patient outcomes, including cure rates, mortality, and morbidity.
• Assessment of the impact of pre- and post-operative medical regimens.
• Evaluation of surgical techniques, including the use of muscle flaps.

Main Results:

• Surgery for MDRTB can be performed with low mortality and morbidity.
• Muscle flaps can effectively minimize postoperative complications.
• A combined approach of surgery and continued medical therapy achieves cure rates exceeding 90% in select patients.
• Surgical intervention is the preferred treatment for MDRTB with localized parenchymal disease.

Conclusions:

• Surgical management, when combined with optimal anti-tuberculous therapy, is a safe and effective option for select patients with drug-resistant tuberculosis.
• Early consideration of surgery in patients with destructive pulmonary processes or persistent positive sputum is warranted.
• This combined treatment strategy offers a high likelihood of cure for challenging MDRTB cases.